Established in 1987, this Manufacturer is a fully integrated biopharmaceutical entity specializing in human insulin, analogue insulin, and GLP-1 agents, offering both drug substances and formulations. As a CTD dossier owner and manufacturer, it provides comprehensive services from proof of concept to commercial scale, including yield optimization and contract manufacturing in vials, ampoules, cartridges, and disposable pens. Operating two manufacturing facilities—one in Taloja, Navi Mumbai, certified with WHO-GMP compliance to PIC standards, and another in Pune adhering to European Medicines Evaluation Agency (EMEA) and US FDA standards—the Manufacturer ensures high-quality production. With a workforce of approximately 500 employees, its products are accredited in over 30 countries and regions worldwide. As a GMP manufacturer, it maintains stringent quality standards across all operations. Committed to global health, this CTD dossier owner and manufacturer continues to expand its presence in regulated markets

This globally operating pharmaceutical company focuses on developing and manufacturing a broad range of affordable medications. They specialize in both prescription and over-the-counter drugs, including oncology treatments, antibacterials, injectables (both specialty and large volume), ophthalmic products, dermatological preparations, and veterinary pharmaceuticals. Their product portfolio also includes unique niche drugs and orphan products, showcasing their commitment to addressing diverse medical needs. The company boasts state-of-the-art manufacturing facilities located across several regions, adhering to strict quality standards recognized by international regulatory bodies like the WHO GMP, US FDA, and MCC. Their extensive global reach spans over 45 countries in Asia, Africa, Latin America, CIS, Europe, Australia, and the Pacific Ocean. The company's focus on research and development, coupled with its global manufacturing capabilities and commitment to quality, positions them as a key player in the international pharmaceutical market.